- Great news for PolyGene and collaborators under the same purpose October 2, 2017
PolyGene AG, together with TargetEx Kft. (Hungary), Intelligent Pharma (Spain) and University of Zürich (Switzerland), received European funding to continue PolyGene’s ambitious research program on gene regulation tools, and to successfully bring these expression systems to the market.
SwitchItOn will generate a toolbox of novel genomic switches, opening new avenues of ...» read more
- One step closer to understanding T-cell leukemia August 9, 2017
T-cell leukemia is rare blood cancer in the own immune system. T-cell acute lymphoblastic leukemia, a special form of T-cell leukemia, was investigated by Belgian researchers with striking findings.
In a recently conducted patient study, a R98S mutation in ribosomal protein L10 recurred in 8% of children with T-cell acute lymphoblastic leukemia.
This protein plays ...» read more